May 29, 2016

The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease: A Systematic Review and Meta-analysis

.   .   

This meta-analysis and systematic review of 17 studies showed that higher hemoglobin targets did not result in statistically or clinically significant differences in SF-36 or KDQ domains.  Furthermore, HRQOL were further attenuated in studies at low risk of bias and in subgroups of dialysis patients.

 

 

Related Articles:

Anemia, Clinical Nephrology